US 11986515
Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)
granted A61KA61K35/761A61K38/465
Quick answer
US patent 11986515 (Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)) held by REGENXBIO INC. expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENXBIO INC.
- Grant date
- Tue May 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K35/761, A61K38/465, A61K45/06, A61K48/005